Calcitriol in cancer treatment: From the lab to the clinic

Skip Nav Destination

Mol Cancer Ther (2004) 3 (3): 373–381.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

In vitro studies revealed a downregulation of Wnt/β-catenin cascade by active vitamin D and TX 527 analog in a Kaposi's sarcoma cellular model

Cinthya Tapia
Alejandra Suares
Pablo De Genaro
Verónica González-Pardo

Toxicology in Vitro (2020) 63: 104748.

Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models

Tapesh Santra
Sandra Roche
Neil Conlon
Norma O’Donovan
John Crown
Robert O’Connor
Walter Kolch
Surinder K. Batra

PLOS ONE (2017) 12 (5): e0177058.

Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG

Justin M. Roberts
Rebeca San Martin
D. Badrajee Piyarathna
James G. MacKrell
Guilherme V. Rocha
Jeffery A. Dodge
Cristian Coarfa
Venkatesh Krishnan
David R. Rowley
Nancy L. Weigel

Oncotarget (2017) 8 (27): 44447.

ADAM10 modulates calcitriol-regulated RAGE in cardiomyocytes

Ting-Wei Lee
Yu-Hsun Kao
Ting-I Lee
Yi-Jen Chen

European Journal of Clinical Investigation (2017) 47 (9): 675.

Regulation of the CCN genes by vitamin D: A possible adjuvant therapy in the treatment of cancer and fibrosis

Richard T. Piszczatowski
Nathan H. Lents

Cellular Signalling (2016) 28 (10): 1604.

The Research Progress of 1,25(OH)₂D₃ Effects on Cervical Cancer

文文周

Asian Case Reports in Oncology (2016) 05 (04): 55.

Improvement of a liposomal formulation with a native molecule: calcitriol

Ali Deniz Dalgic
Aysen Tezcaner
Pinar Elci
Meral Sarper
Fikret Arpaci
Ferit Avcu
Dilek Keskin

RSC Advances (2016) 6 (83): 80158.

Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients

Jacques Medioni
Gael Deplanque
Jean-Marc Ferrero
Tristan Maurina
Jean-Michel P. Rodier
Eric Raymond
Jorge Allyon
Gerard Maruani
Pascal Houillier
Sarah Mackenzie
Stephanie Renaux
Jean-Francois Dufour-Lamartinie
Reza Elaidi
Celine Lerest
Stephane Oudard

Clinical Cancer Research (2014) 20 (17): 4471.

Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1α,25-dihydroxyvitamin D3 in prostate cancer cells

Yong Xu
Fang Fang
Daret K. St. Clair
Sajni Josson
Pradoldej Sompol
Ivan Spasojevic
William H. St. Clair

Molecular Cancer Therapeutics (2007) 6 (7): 2048.

Chemoprevention of Prostate Cancer through Dietary Agents: Progress and Promise

Deeba N. Syed
Naghma Khan
Farrukh Afaq
Hasan Mukhtar

Cancer Epidemiology, Biomarkers & Prevention (2007) 16 (11): 2193.

Promise of vitamin D analogues in the treatment of hyperproliferative conditions

Sonoko Masuda
Glenville Jones

Molecular Cancer Therapeutics (2006) 5 (4): 797.

Effect of Calcitriol on Prostate-Specific Antigen In vitro and in Humans

Tomasz M. Beer
Mark Garzotto
Byung Park
Motomi Mori
Anne Myrthue
Nicole Janeba
David Sauer
Kristine Eilers

Clinical Cancer Research (2006) 12 (9): 2812.

Vitamin D Inhibits the Formation of Prostatic Intraepithelial Neoplasia in Nkx3.1; Pten Mutant Mice

Whitney Banach-Petrosky
Xuesong Ouyang
Hui Gao
Kamyar Nader
Yan Ji
Nanjoo Suh
Robert S. DiPaola
Cory Abate-Shen

Clinical Cancer Research (2006) 12 (19): 5895.

Pharmacokinetics and Tolerability of a Single Dose of DN-101, a New Formulation of Calcitriol, in Patients with Cancer

Tomasz M. Beer
Milind Javle
Gilbert N. Lam
W. David Henner
Alvin Wong
Donald L. Trump

Clinical Cancer Research (2005) 11 (21): 7794.

Sun Exposure, Vitamin D Receptor Gene Polymorphisms, and Risk of Advanced Prostate Cancer

Esther M. John
Gary G. Schwartz
Jocelyn Koo
David Van Den Berg
Sue A. Ingles

Cancer Research (2005) 65 (12): 5470.

Calcitriol in cancer treatment: From the lab to the clinic

AACR Journals

This Feature Is Available To Subscribers Only